Sun Pharma import ban back in force after Squires intervention

A decision at the USPTO has cleared the way for renewed enforcement in the drugmaker’s dispute over light-based dermatology tech.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com

More on this story

MedTech

Boston Scientific expands dispute with J&J unit over cardiac-access technology

12 October 2026 The two major medical device makers are clashing over Atraverse’s Hotwire system, with Boston Scientific claiming the product infringes its patented radiofrequency transseptal-access technology, used in heart surgery.

MedTech

Abbott clinches 18-country PI in glucose monitoring feud

9 September 2026 The UPC has handed the medical device company a significant win over continuous glucose monitoring tech, granting a broad provisional injunction after finding that SiBio’s rival system was likely to infringe its European patent.

MedTech

Abbott fends off Chinese rival’s patent challenge at UPC

18 August 2026 The European court has backed Abbott in a dispute over glucose-monitoring technology, while offering guidance on a key added-matter issue.

More features

Boston Scientific expands dispute with J&J unit over cardiac-access technology

Brazilian firm appoints patent strategist to lead department

AIPPI World Congress: ‘Diversity need not be an obstacle to unity’

Novartis pursues Apotex over copies of $2bn skin cancer drug franchise

MSD’s Keytruda hit by eight-country ban across Europe

Foley Hoag adds two partners in Denver expansion

WATCH: LEO Pharma head of IP rights on doing more with less

Dr Reddy’s v Boehringer: Data gaps take centre stage in courtroom

Sun Pharma import ban back in force after Squires intervention

More on this story

Editor's picks

Editor's picks

More features